Advanced glycation end product - Induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1

American Journal of Kidney Diseases

Volumn 38, Issue 5, 2001, Pages 1096-1104

  Guh, Jinn Yuh ^a   Huang, Jau Shyang ^a   Chen, Hung Chun ^a   Hung, Wen Chun ^a   Lai, Yung Hsiung ^a   Chuang, Lea Yea ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Advanced glycation end product (AGE); Cyclin D1; Diabetic nephropathy (DN); Fibroblast; Janus kinase (JAK) signal transducers and activators of transcription (STAT)

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; JANUS KINASE; OLIGODEOXYNUCLEOTIDE; PROTEIN P21; STAT5 PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; FIBROBLAST; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MITOGENESIS; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

EID: 0034748225     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.28616     Document Type: Article

References (44)

1. Pathogenesis, prevention, and treatment of diabetic nephropathy
2. Renal fibrosis: An update
3. Advanced glycation end products: A nephrologist's perspective
4. Role of the janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells
5. Cell cycle regulation in diabetic nephropathy
6. G1 Kinases and transforming growth factor-beta signaling are associated with a growth pattern switch in diabetes-induced renal growth
7. Renal enlargement precedes renal hyperfiltration in early experimental diabetes in rats
8. Omithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes
9. The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?
10. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis
11. Cyclins and cell cycle checkpoints
12. Interaction between high glucose and transforming growth factor-β in cell cycle protein regulations in MDCK cells
13. Cellular responses to interferons and other cytokines: The JAK-STAT paradigm
14. STATs and gene regulation
15. STAT family of transcription factors in cytokine-mediated biological responses
16. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
17. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease
18. Stat5a and Stat5b: Fraternal twins of signal transduction and transcriptional activation
19. Stat5 is a physiological substrate of the insulin receptor
20. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes
21. A novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotides
22. Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a
23. Extracellular signals and intracellular pathways in diabetic nephropathy
24. Design and baseline characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)
25. Myofibroblasts and the progression of diabetic nephropathy
26. The biology of the receptor for advanced glycation end products and its ligands
27. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress
28. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F Cells
29. Cyclin D1 production in cycling cells depends on ras in a cell-cycle-specific manner
30. Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression
31. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry
32. Transcriptional activation of the cyclin D1 gene is mediated by multiple cis-elements including SP1 sites and a cyclic AMP responsive element in vascular endothelial cells
33. STAT signaling in cell proliferation and in development
34. Ras and signal transducer and activator of transcription (STAT) are essential and sufficient downstream components of janus kinases in cell proliferation
35. The Jak-Stat pathway in normal and perturbed hematopoiesis
36. STAT signalling in the mature and aging brain
37. Upregulation and activation of Stat6 precede vascular smooth muscle cell proliferation in carotid artery injury model
38. Requirement of cyclin D1 in mesangial cell mitogenesis
39. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression
40. Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest
41. Gene therapy for renal fibroblasts
42. Gene transfer targeting interstitial fibroblasts by the artificial viral envelope-type hemagglutinating virus of Japan liposome method
43. Renal collagen synthesis and its control
44. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts